Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


Articles published in Transplantation

Retrieve available abstracts of 120 articles:
HTML format
Text format



Single Articles


    July 2018
  1. GADSDEN MM, Goldberg DS
    Hepatic Dysfunction in Deceased Donors in the Age of the Opioid Epidemic.
    Transplantation. 2018 Jul 13. doi: 10.1097/TP.0000000000002368.
    PubMed     Text format    


  2. BARBIER L, Bucur P, Salame E
    Extended-criteria allografts a strategy to reduce waiting list mortality in selected hepatocellular carcinoma recipients.
    Transplantation. 2018 Jul 13. doi: 10.1097/TP.0000000000002365.
    PubMed     Text format    


  3. HEITS N, Brosch M, Herrmann A, Behrens R, et al
    EVOLUTIONARY DISTANCE PREDICTS RECURRENCE AFTER LIVER TRANSPLANTATION IN MULTIFOCAL HEPATOCELLULAR CARCINOMA.
    Transplantation. 2018 Jul 9. doi: 10.1097/TP.0000000000002356.
    PubMed     Text format     Abstract available


  4. THULUVATH PJ, Hanish S, Savva Y
    Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared to Cryptogenic, Alcoholic or AIH Cirrhosis.
    Transplantation. 2018 Jul 5. doi: 10.1097/TP.0000000000002355.
    PubMed     Text format     Abstract available


  5. DOMEN J
    Minimally invasive transplantation of primary human hepatocyte inserts that facilitate vascularization.
    Transplantation. 2018 Jul 3. doi: 10.1097/TP.0000000000002331.
    PubMed     Text format    


    June 2018
  6. SEALE N, Ramaswamy S, Shih YR, Verma I, et al
    Macroporous dual compartment hydrogels for minimally invasive transplantation of primary human hepatocytes.
    Transplantation. 2018 Jun 18. doi: 10.1097/TP.0000000000002330.
    PubMed     Text format     Abstract available


  7. MIYAAKI H, Miuma S, Taura N, Shibata H, et al
    Risk factors and clinical course for liver steatosis or nonalcoholic steatohepatitis after living donor liver transplantation.
    Transplantation. 2018 Jun 11. doi: 10.1097/TP.0000000000002319.
    PubMed     Text format     Abstract available


    May 2018
  8. LI F, Jiao A, Li X, Zhang C, et al
    Survival and Metabolic Function of Syngeneic Mouse Islet Grafts Transplanted into the Hepatic Sinus-tract.
    Transplantation. 2018 May 22. doi: 10.1097/TP.0000000000002289.
    PubMed     Text format     Abstract available


  9. RODRIGUEZ-PERALVAREZ M, Guerrero M, Barrera L, Ferrin G, et al
    Impact of Early Initiated Everolimus on the Recurrence of Hepatocellular Carcinoma after Liver Transplantation.
    Transplantation. 2018 May 11. doi: 10.1097/TP.0000000000002270.
    PubMed     Text format     Abstract available


  10. PARKER A, Karvellas CJ
    Coagulation Defects in the Cirrhotic Patient Undergoing Liver Transplantation.
    Transplantation. 2018 May 7. doi: 10.1097/TP.0000000000002273.
    PubMed     Text format     Abstract available


    April 2018
  11. HOGEN R, Lo M, DiNorcia J, Ji L, et al
    More Than Just Wait Time? Regional Differences in Liver Transplant Outcomes for Hepatocellular Carcinoma.
    Transplantation. 2018 Apr 18. doi: 10.1097/TP.0000000000002248.
    PubMed     Text format     Abstract available


    February 2018
  12. KIM JM, Kwon CHD, Joh JW, Han S, et al
    ABO-incompatible Living Donor Liver Transplantation with Rituximab and Total Plasma Exchange Does Not Increase Hepatocellular Carcinoma Recurrence.
    Transplantation. 2018 Feb 28. doi: 10.1097/TP.0000000000002154.
    PubMed     Text format     Abstract available


  13. RHU J, Kim JM, Choi GS, Kwon CHD, et al
    Validation of the alpha-fetoprotein model for hepatocellular carcinoma recurrence after transplantation in an Asian population.
    Transplantation. 2018 Feb 20. doi: 10.1097/TP.0000000000002136.
    PubMed     Text format     Abstract available


  14. THULUVATH AJ, Chen PH, Thuluvath PJ, Kantsevoy S, et al
    Poor Survival after Retransplantation in NASH cirrhosis.
    Transplantation. 2018 Feb 20. doi: 10.1097/TP.0000000000002135.
    PubMed     Text format     Abstract available


    January 2018
  15. QUARELLO P, Tandoi F, Carraro F, Vassallo E, et al
    Successful sequential liver and haematopoietic stem cell transplantation in a child with CD40 ligand deficiency and Cryptosporidium-induced liver cirrhosis.
    Transplantation. 2018 Jan 26. doi: 10.1097/TP.0000000000002114.
    PubMed     Text format     Abstract available


  16. GIARD JM, Mehta N, Dodge JL, Roberts JP, et al
    Alpha-fetoprotein Slope >7.5 ng/ml/month Predicts Micro-vascular Invasion and Tumor Recurrence after Liver Transplantation for Hepatocellular Carcinoma.
    Transplantation. 2018 Jan 17. doi: 10.1097/TP.0000000000002094.
    PubMed     Text format     Abstract available


  17. ECKER BL, Hoteit MA, Forde KA, Hsu CC, et al
    Patterns of Discordance Between Pretransplant Imaging Stage of Hepatocellular Carcinoma and Posttransplant Pathologic Stage: A Contemporary Appraisal of the Milan Criteria.
    Transplantation. 2018 Jan 10. doi: 10.1097/TP.0000000000002056.
    PubMed     Text format     Abstract available


  18. SADLER EM, Mehta N, Bhat M, Ghanekar A, et al
    Liver transplantation for NASH-related hepatocellular carcinoma versus non-NASH etiologies of hepatocellular carcinoma.
    Transplantation. 2018 Jan 10. doi: 10.1097/TP.0000000000002043.
    PubMed     Text format     Abstract available


    December 2017
  19. IANNELLI A, Schiavo L
    Very low-calorie diet, the morbidly obese with liver cirrhosis and bariatric surgery.
    Transplantation. 2017 Dec 22. doi: 10.1097/TP.0000000000002065.
    PubMed     Text format    


  20. SPENGLER EK
    The Author's Reply: Very low-calorie diet, the morbidly obese with liver cirrhosis and bariatric surgery.
    Transplantation. 2017 Dec 22. doi: 10.1097/TP.0000000000002064.
    PubMed     Text format    


  21. THULUVATH PJ, Hanish S, Savva Y
    Liver Transplantation in Cryptogenic Cirrhosis: Outcome comparisons between NASH, Alcoholic and AIH cirrhosis.
    Transplantation. 2017 Dec 5. doi: 10.1097/TP.0000000000002030.
    PubMed     Text format     Abstract available


    November 2017
  22. PUCHADES L, Chau S, Dodson JA, Mohamad Y, et al
    Association of Cardiac Abnormalities to the Frail Phenotype in Cirrhotic Patients on the Waitlist: From the Functional Assessment in Liver Transplantation (FrAILT) Study.
    Transplantation. 2017 Nov 20. doi: 10.1097/TP.0000000000002025.
    PubMed     Text format     Abstract available


  23. LI CX, Man K, Lo CM
    The Impact of Liver Graft Injury on Cancer Recurrence Posttransplantation.
    Transplantation. 2017;101:2665-2670.
    PubMed     Text format     Abstract available


  24. GREY ST, Issa F
    The 2017 Transplantation Awards: Recognizing a Landmark Clinical Trial and a Basic Science Discovery With Far-Reaching Implications.
    Transplantation. 2017;101:2655-2656.
    PubMed     Text format    


    October 2017
  25. REYMOND M, Barbier L, Salame E, Besh C, et al
    Does Portopulmonary Hypertension Impede Liver Transplantation in Cirrhotic Patients? A French Multicentric Retrospective Study.
    Transplantation. 2017 Oct 26. doi: 10.1097/TP.0000000000001981.
    PubMed     Text format     Abstract available


  26. SPENGLER EK, O'Leary JG, Te HS, Rogal S, et al
    Liver Transplantation in the Obese Cirrhotic Patient.
    Transplantation. 2017;101:2288-2296.
    PubMed     Text format     Abstract available


  27. WENG J, Li W, Jia X, An W, et al
    Alleviation of Ischemia-Reperfusion Injury in Liver Steatosis by Augmenter of Liver Regeneration Is Attributed to Antioxidation and Preservation of Mitochondria.
    Transplantation. 2017;101:2340-2348.
    PubMed     Text format     Abstract available


  28. O'LEARY JG, Demetris AJ, Philippe A, Freeman R, et al
    Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts.
    Transplantation. 2017;101:2399-2409.
    PubMed     Text format     Abstract available


    September 2017
  29. CITRO A, Cantarelli E, Pellegrini S, Dugnani E, et al
    Antiinflammatory strategies in intrahepatic islet transplantation: a comparative study in preclinical models.
    Transplantation. 2017 Sep 8. doi: 10.1097/TP.0000000000001925.
    PubMed     Text format     Abstract available


  30. WEICHEN Z, Feibo L, Yufu Y, Yuanxing L, et al
    Isoglycyrrhizinate magnesium enhances hepatoprotective effect of FK506 on ischemia-reperfusion injury through HMGB1 inhibition in a rat model of liver transplantation.
    Transplantation. 2017 Sep 6. doi: 10.1097/TP.0000000000001941.
    PubMed     Text format     Abstract available


  31. SNEIDERS D, Houwen T, Pengel LHM, Polak WG, et al
    Systematic review and meta-analysis of posttransplant hepatic artery and biliary complications in patients treated with transarterial chemoembolization before liver transplantation.
    Transplantation. 2017 Sep 6. doi: 10.1097/TP.0000000000001936.
    PubMed     Text format     Abstract available


    August 2017
  32. CHARLTON M, Rinella M, Patel D, McCague K, et al
    Everolimus is Associated With Less Weight Gain Than Tacrolimus 2 Years Following Liver Transplantation: Results of a Randomized Multicenter Study.
    Transplantation. 2017 Aug 15. doi: 10.1097/TP.0000000000001913.
    PubMed     Text format     Abstract available


  33. DOSHI SD, Bittermann T, Schiano TD, Goldberg DS, et al
    Waitlisted Candidates With Polycystic Liver Disease Are More Likely to be Transplanted Than Those With Chronic Liver Failure.
    Transplantation. 2017;101:1838-1844.
    PubMed     Text format     Abstract available


  34. ICHAI P, Laurent-Bellue A, Saliba F, Moreau D, et al
    Acute Liver Failure/Injury Related to Drug Reaction With Eosinophilia and Systemic Symptoms: Outcomes and Prognostic Factors.
    Transplantation. 2017;101:1830-1837.
    PubMed     Text format     Abstract available


  35. STINE JG, Intagliata N, Northup PG, Caldwell SH, et al
    Nonalcoholic Fatty Liver Disease, Portal Vein Thrombosis and Coagulation: More Questions Than Answers?
    Transplantation. 2017;101:e281-e282.
    PubMed     Text format    


    July 2017
  36. BOYLAN JM, Francois-Vaughan H, Gruppuso PA, Sanders JA, et al
    Engraftment and Repopulation Potential of Late Gestation Fetal Rat Hepatocytes.
    Transplantation. 2017 Jul 27. doi: 10.1097/TP.0000000000001882.
    PubMed     Text format     Abstract available


  37. LI Y, Ma D, Wang Z, Yang J, et al
    MicroRNA-155 Deficiency in Kupffer Cells Ameliorates Liver Ischemia-Reperfusion Injury in Mice.
    Transplantation. 2017;101:1600-1608.
    PubMed     Text format     Abstract available


  38. DUBROCK HM, Goldberg DS, Sussman NL, Bartolome SD, et al
    Predictors of Waitlist Mortality in Portopulmonary Hypertension.
    Transplantation. 2017;101:1609-1615.
    PubMed     Text format     Abstract available


  39. JOCHMANS I, van Rosmalen M, Pirenne J, Samuel U, et al
    Adult Liver Allocation in Eurotransplant.
    Transplantation. 2017;101:1542-1550.
    PubMed     Text format     Abstract available


  40. DESCAMPS V, Brunet-Possenti F
    Human Herpesvirus 6 Reactivation in DRESS With Acute Liver Failure: A Missing Key Factor.
    Transplantation. 2017;101:e224-e225.
    PubMed     Text format    


    June 2017
  41. KIM PT, Klintmalm GB
    Authors' Reply: Does low Hepatic Artery Flow Increase Rate of Biliary Strictures in Deceased Donor Liver Transplantation?
    Transplantation. 2017 Jun 21. doi: 10.1097/TP.0000000000001855.
    PubMed     Text format    


  42. YI Z, Mayorga ME, Orman ES, Wheeler SB, et al
    Trends in Characteristics of Patients Listed for Liver Transplantation Will Lead to Higher Rates of Waitlist Removal Due to Clinical Deterioration.
    Transplantation. 2017 Jun 20. doi: 10.1097/TP.0000000000001851.
    PubMed     Text format     Abstract available


    May 2017
  43. EMOND JC, Goodrich NP, Pomposelli JJ, Baker TB, et al
    Hepatic hemodynamics and portal flow modulation: The A2ALL experience.
    Transplantation. 2017 May 17. doi: 10.1097/TP.0000000000001823.
    PubMed     Text format     Abstract available


  44. KENSINGER CD, Feurer ID, Karp SJ
    An Outcome-Based Approach to Assign MELD Exception Points for Patients With Hepatocellular Cancer.
    Transplantation. 2017 May 4. doi: 10.1097/TP.0000000000001812.
    PubMed     Text format     Abstract available


  45. CHENG XS, Stedman MR, Chertow GM, Kim WR, et al
    Utility in Treating Kidney Failure in End-Stage Liver Disease With Simultaneous Liver-Kidney Transplantation.
    Transplantation. 2017;101:1111-1119.
    PubMed     Text format     Abstract available


    March 2017
  46. MEHTA N, Heimbach J, Lee D, Dodge JL, et al
    Wait Time of < 6 and > 18 Months Predicts Hepatocellular Carcinoma Recurrence after Liver Transplantation: Proposing a Wait Time "Sweet Spot".
    Transplantation. 2017 Mar 28. doi: 10.1097/TP.0000000000001752.
    PubMed     Text format     Abstract available


  47. NEKRASOV V, Matsuoka L, Kaur N, Pita A, et al
    Improvement in the Outcomes of MELD >/= 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA.
    Transplantation. 2017 Mar 18. doi: 10.1097/TP.0000000000001738.
    PubMed     Text format     Abstract available


  48. BHATI C, Idowu MO, Sanyal AJ, Rivera M, et al
    Long Term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis Related Cirrhosis.
    Transplantation. 2017 Mar 15. doi: 10.1097/TP.0000000000001709.
    PubMed     Text format     Abstract available


  49. MURALI AR, Patil S, Phillips KT, Voigt M, et al
    Locoregional Therapy with Curative Intent versus Primary Liver Transplant for Hepatocellular Carcinoma: Systematic Review and Meta-analysis.
    Transplantation. 2017 Mar 10. doi: 10.1097/TP.0000000000001730.
    PubMed     Text format     Abstract available


  50. LAI Q, Feys E, Karam V, Adam R, et al
    Hepatic Epithelioid Hemangioendothelioma and Adult Liver Transplantation: Proposal for a Prognostic Score Based on the Analysis of the ELTR-ELITA Registry.
    Transplantation. 2017;101:555-564.
    PubMed     Text format     Abstract available


    February 2017
  51. PALUMBO T, Nakamura K, Lassman C, Kidani Y, et al
    Bruton Tyrosine Kinase Inhibition Attenuates Liver Damage in a Mouse Warm Ischemia and Reperfusion Model.
    Transplantation. 2017;101:322-331.
    PubMed     Text format     Abstract available


  52. REDDY MS, Rajalingam R, Rela M
    Revisiting APOLT for Metabolic Liver Disease: A New Look at an Old Idea.
    Transplantation. 2017;101:260-266.
    PubMed     Text format     Abstract available


    January 2017
  53. BITTERMANN T, Goldberg DS, Bauer CM, Khungar V, et al
    Characterizing the risk of false-positive hepatocellular carcinoma in recipients transplanted with T2 MELD exceptions.
    Transplantation. 2017 Jan 25. doi: 10.1097/TP.0000000000001660.
    PubMed     Text format     Abstract available


  54. SATAPATHY SK, Vanatta JM, Helmick R, Flowers A, et al
    Outcome of Liver Transplant Recipients With Revascularized Coronary Artery Disease: A Comparative Analysis With and Without Cardiovascular Risk Factors.
    Transplantation. 2017 Jan 17. doi: 10.1097/TP.0000000000001647.
    PubMed     Text format     Abstract available


  55. VINAIXA C, Strasser SI, Berenguer M
    DISEASE REVERSIBILITY IN PATIENTS WITH POSTHEPATITIS C CIRRHOSIS: IS THE POINT OF NO RETURN THE SAME BEFORE AND AFTER LIVER TRANSPLANTATION? A REVIEW.
    Transplantation. 2017 Jan 6. doi: 10.1097/TP.0000000000001633.
    PubMed     Text format     Abstract available


  56. RICH N, Tanriover B, Singal AG, Marrero JA, et al
    Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma.
    Transplantation. 2017;101:e12-e19.
    PubMed     Text format     Abstract available


  57. LIU D, Chan AC, Fong DY, Lo CM, et al
    Evidence-Based Surveillance Imaging Schedule After Liver Transplantation for Hepatocellular Carcinoma Recurrence.
    Transplantation. 2017;101:107-111.
    PubMed     Text format     Abstract available


  58. DEMARTINO ES, Cartin-Ceba R, Findlay JY, Heimbach JK, et al
    Frequency and Outcomes of Patients With Increased Mean Pulmonary Artery Pressure at the Time of Liver Transplantation.
    Transplantation. 2017;101:101-106.
    PubMed     Text format     Abstract available


    December 2016
  59. KIM PT, Fernandez H, Gupta A, Saracino G, et al
    Low measured hepatic artery flow increases rate of biliary strictures in deceased donor liver transplantation: An age dependent phenomenon.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  60. LAI Q, Feys E, Karam V, Adam R, et al
    HEPATIC EPITHELIOID HEMANGIO-ENDOTHELIOMA AND ADULT LIVER TRANSPLANTATION: PROPOSAL FOR A PROGNOSTIC SCORE BASED ON THE ANALYSIS OF THE ELTR-ELITA REGISTRY.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  61. SALAZAR J, Saxena V, Kahn JG, Roberts JP, et al
    Cost-Effectiveness of Direct-Acting Anti-viral Treatment in Hepatitis C-infected Liver Transplant Candidates with Compensated Cirrhosis and Hepatocellular Carcinoma.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    November 2016
  62. MURALI AR, Romero-Marrero C, Miller C, Aucejo F, et al
    Predictors of Successful Downstaging of Hepatocellular Carcinoma Outside Milan Criteria.
    Transplantation. 2016;100:2391-2397.
    PubMed     Text format     Abstract available


  63. ZAHR ELDEEN F, Roll GR, Derosas C, Rao R, et al
    Preoperative Thromboelastography as a Sensitive Tool Predicting Those at Risk of Developing Early Hepatic Artery Thrombosis After Adult Liver Transplantation.
    Transplantation. 2016;100:2382-2390.
    PubMed     Text format     Abstract available


  64. KRAWCZYK M, Grat M, Adam R, Polak WG, et al
    Liver Transplantation for Hepatic Trauma: A Study From the European Liver Transplant Registry.
    Transplantation. 2016;100:2372-2381.
    PubMed     Text format     Abstract available


    August 2016
  65. POMPOSELLI JJ
    Hepatic Artery Thrombosis (HAT) After Liver Transplant: Not A Surgical Problem?
    Transplantation. 2016.
    PubMed     Text format    


  66. MOHKAM K, Fanget F, Darnis B, Harbaoui B, et al
    Use of systemic vasodilators for the management of Doppler ultrasound arterial abnormalities after orthotopic liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  67. FURUICHI M, Fujiwara T, Fukuda A, Kasahara M, et al
    Fulminant hepatic failure as a risk factor for cytomegalovirus infection in children receiving preemptive therapy after living donor liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  68. DE CARLIS L, De Carlis R, Lauterio A, Di Sandro S, et al
    Sequential use of normothermic regional perfusion and hypothermic machine perfusion in donation after cardiac death liver transplantation with extended warm ischemia time.
    Transplantation. 2016.
    PubMed     Text format    


  69. TAPPER EB, Hughes MS, Buti M, Dufour JF, et al
    The optimal timing of hepatitis C therapy in transplant eligible patients with Child B and C Cirrhosis: A Cost-Effectiveness Analysis.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  70. HAMAGUCHI Y, Kaido T, Okumura S, Kobayashi A, et al
    Proposal of Muscle-MELD score, including muscularity, for prediction of mortality after living donor liver transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  71. CICALESE L, Shirafkan A, Jennings K, Zorzi D, et al
    Increased risk of death for patients on the waitlist for liver transplant residing at greater distance from specialized liver transplant centers in the USA.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  72. HART A, Schladt DP, Zeglin J, Pyke J, et al
    Predicting outcomes on the liver transplant waiting list in the United States: Accounting for large regional variation in organ availability and priority allocation points.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  73. MURALI AR, Chandra S, Stewart Z, Blazar BR, et al
    Graft versus Host Disease After Liver Transplantation in Adults: A Case series, Review of Literature, and an Approach to Management.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    July 2016
  74. GYOTEN K, Mizuno S, Kato H, Murata Y, et al
    A novel predictor of posttransplant portal hypertension in adult-to-adult living donor liver transplantation: increased estimated spleen/graft volume ratio.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  75. GOODRICH NP, Schaubel DE, Smith AR, Merion RM, et al
    National Assessment of Hospitalization Rates for Incident End Stage Renal Disease after Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  76. SIMKINS J, Abbo LM, Camargo JF, Rosa R, et al
    Twelve-Week Rifapentine Plus Isoniazid Versus 9-Month Isoniazid for the Treatment of Latent Tuberculosis in Renal Transplant Candidates.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  77. KROWKA MJ, Fallon MB, Kawut SM, Fuhrmann V, et al
    International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension.
    Transplantation. 2016;100:1440-52.
    PubMed     Text format     Abstract available


  78. SULLIVAN T, Weinberg A, Rana M, Patel G, et al
    The Epidemiology and Clinical Features of Clostridium difficile Infection in Liver Transplant Recipients.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  79. POMPOSELLI JJ, Goodrich NP, Emond JC, Humar A, et al
    Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience.
    Transplantation. 2016;100:1490-9.
    PubMed     Text format     Abstract available


    June 2016
  80. HAN S, Yang JD, Sinn DH, Ko JS, et al
    Higher Bilirubin Levels of Healthy Living Liver Donors Are Associated With Lower Posttransplant Hepatocellular Carcinoma Recurrence.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  81. GEISSLER EK, Schnitzbauer AA, Schlitt HJ
    A Rebuttal Letter in Response to: Mammalian Target of Rapamycin Inhibitors Against Hepatocellular Carcinoma Recurrence After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format    


  82. CHOLONGITAS E
    Mammalian Target of Rapamycin Inhibitors Against Hepatocellular Carcinoma Recurrence After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format    


  83. HSU CC, Chen CL, Wang CC, Lin CC, et al
    Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  84. WANG CW, Feng S, Covinsky KE, Hayssen H, et al
    A Comparison of Muscle Function, Mass, and Quality in Liver Transplant Candidates: Results From the Functional Assessment in Liver Transplantation Study.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  85. SALVALAGGIO PR, Seda Neto J, Alves JA, Fonseca EA, et al
    Consensus, Dilemmas, and Challenges in Living Donor Liver Transplantation in Latin America.
    Transplantation. 2016;100:1161-4.
    PubMed     Text format     Abstract available


    May 2016
  86. DEW MA, DiMartini AF, Ladner DP, Simpson MA, et al
    Psychosocial Outcomes 3 to 10 Years After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


    April 2016
  87. DE CARLIS L, Lauterio A, De Carlis R, Ferla F, et al
    Donation After Cardiac Death Liver Transplantation After More Than 20 Minutes of Circulatory Arrest and Normothermic Regional Perfusion.
    Transplantation. 2016;100:e21-2.
    PubMed     Text format    


  88. KIMURA K, Shirabe K, Yoshizumi T, Takeishi K, et al
    Ischemia-Reperfusion Injury in Fatty Liver Is Mediated by Activated NADPH Oxidase 2 in Rats.
    Transplantation. 2016;100:791-800.
    PubMed     Text format     Abstract available


    March 2016
  89. SEDA-NETO J, Antunes da Fonseca E, Pugliese R, Candido HL, et al
    Twenty Years of Experience in Pediatric Living Donor Liver Transplantation: Focus on Hepatic Artery Reconstruction, Complications and Outcomes.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  90. CAO Y, Shahrestani S, Chew HC, Crawford M, et al
    Donation After Circulatory Death for Liver Transplantation: A Meta-Analysis on the Location of Life Support Withdrawal Affecting Outcomes.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  91. VANDEKERCKHOVE K, Coomans I, De Bruyne E, De Groote K, et al
    Evaluation of Exercise Performance, Cardiac Function, and Quality of Life in Children After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  92. KHORSANDI SE, Yip VS, Cortes M, Jassem W, et al
    Does Donation After Cardiac Death Utilization Adversely Effect Hepatocellular Cancer Survival?
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  93. FOSTER BJ, Dahhou M, Zhang X, Dharnidharka VR, et al
    High Risk of Liver Allograft Failure During Late Adolescence and Young Adulthood.
    Transplantation. 2016;100:577-84.
    PubMed     Text format     Abstract available


    February 2016
  94. WESTERKAMP AC, Karimian N, Matton AP, Mahboub P, et al
    Oxygenated Hypothermic Machine Perfusion After Static Cold Storage Improves Hepatobiliary Function of Extended Criteria Donor Livers.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  95. TOUSSAINT A, Weiss E, Khoy-Ear L, Janny S, et al
    Prognostic Value of Preoperative Brain Natriuretic Peptide Serum Levels in Liver Transplantation.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  96. ZHOU H, Zhu J, Yue S, Lu L, et al
    The Dichotomy of Endoplasmic Reticulum Stress Response in Liver Ischemia-Reperfusion Injury.
    Transplantation. 2016;100:365-72.
    PubMed     Text format     Abstract available


    January 2016
  97. POURCHER G, El-Kehdy H, Kanso F, Groyer-Picard MT, et al
    Volumetric Portal Embolization: A New Concept to Improve Liver Regeneration and Hepatocyte Engraftment.
    Transplantation. 2016.
    PubMed     Text format     Abstract available


  98. POMFRET EA
    Killing Two Birds With One Stone: Antineoplastic Immunosuppression.
    Transplantation. 2016;100:14-5.
    PubMed     Text format    


  99. LEUVENINK HG
    Warming Up--Not Only Essential for Athletes?
    Transplantation. 2016;100:10-1.
    PubMed     Text format    


  100. HOYER DP, Mathe Z, Gallinat A, Canbay AC, et al
    Controlled Oxygenated Rewarming of Cold Stored Livers Prior to Transplantation: First Clinical Application of a New Concept.
    Transplantation. 2016;100:147-52.
    PubMed     Text format     Abstract available


  101. VIJGEN S, Wyss C, Meylan P, Bisig B, et al
    Fatal Outcome of Multiple Clinical Presentations of Human Herpesvirus 8-related Disease After Solid Organ Transplantation.
    Transplantation. 2016;100:134-40.
    PubMed     Text format     Abstract available


    December 2015
  102. TANIMINE N, Tanaka Y, Abe T, Piao J, et al
    Functional Behavior of NKp46-Positive Intrahepatic Natural Killer Cells Against Hepatitis C Virus Reinfection After Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  103. DOYCHEVA I, Leise MD, Watt KD
    The Intestinal Microbiome and the Liver Transplant Recipient: What We Know and What We Need to Know.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    November 2015
  104. MAS V, Archer KJ, Maluf D
    The High-Risk Age Window After Pediatric Liver Transplantation: Modeling Allograft Loss Using Mathematical Tools.
    Transplantation. 2015.
    PubMed     Text format    


  105. MARIANTE-NETO G, Brandao AB
    Model for End-Stage Liver Disease: Is Sex-Based Creatinine Correction a Viable Strategy for Black Females?
    Transplantation. 2015;99:2337-40.
    PubMed     Text format     Abstract available


  106. NOBEL YR, Goldberg DS
    Variable Use of Model for End-Stage Liver Disease Exception Points in Patients With Neuroendocrine Tumors Metastatic to the Liver and Its Impact on Patient Outcomes.
    Transplantation. 2015;99:2341-6.
    PubMed     Text format     Abstract available


    September 2015
  107. CHOI Y, Yi NJ, Ko JS, Moon JS, et al
    Reappraisal of the Role of Portacaval Shunting in the Growth of Patients With Glycogen Storage Disease Type I in the Era of Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  108. MANGUS RS, Fridell JA, Kubal CA, Loeffler AL, et al
    Worse Long-term Patient Survival and Higher Cancer Rates in Liver Transplant Recipients With a History of Smoking.
    Transplantation. 2015;99:1862-1868.
    PubMed     Text format     Abstract available


  109. MANGUS RS, Lutz AJ, Fridell JA, Kubal CA, et al
    Minimal Improvement in Glomerular Filtration Rate in the First Year After Liver Transplantation.
    Transplantation. 2015;99:1855-1861.
    PubMed     Text format     Abstract available


  110. ERICZON BG, Wilczek HE, Larsson M, Wijayatunga P, et al
    Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?
    Transplantation. 2015;99:1847-1854.
    PubMed     Text format     Abstract available


  111. PARAJULI S, Foley D, Djamali A, Mandelbrot D, et al
    Renal Function and Transplantation in Liver Disease.
    Transplantation. 2015;99:1756-64.
    PubMed     Text format     Abstract available


  112. IACOB S, Cicinnati VR, Lindemann M, Heinemann FM, et al
    Donor-Specific Anti-HLA Antibodies and Endothelial C4d Deposition-Association With Chronic Liver Allograft Failure.
    Transplantation. 2015;99:1869-75.
    PubMed     Text format     Abstract available


    June 2015
  113. GHABRIL M, Agarwal S, Lacerda M, Chalasani N, et al
    Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    May 2015
  114. CHENG Q, He SQ, Gao D, Lei B, et al
    Early Application of Auxiliary Partial Orthotopic Liver Transplantation in Murine Model of Wilson Disease.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  115. HAYASHI K, Uchida H, Takaoka C, Izawa Y, et al
    Discrepancy in Psychological Attitudes Toward Living Donor Liver Transplantation Between Recipients and Donors.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  116. LONGENECKER JC, Estrella MM, Segev DL, Atta MG, et al
    Patterns of Kidney Function Before and After Orthotopic Liver Transplant: Associations With Length of Hospital Stay, Progression to End-Stage Renal Disease, and Mortality.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


  117. MOROSO V, van Cranenbroek B, Mancham S, Sideras K, et al
    Prominent HLA-G Expression in Liver Disease But Not After Liver Transplantation.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    March 2015
  118. SCHIEFER J, Lebherz-Eichinger D, Erdoes G, Berlakovich G, et al
    Alterations of Endothelial Glycocalyx During Orthotopic Liver Transplantation in Patients With End-Stage Liver Disease.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    February 2015
  119. MANCIA C, Loustaud-Ratti V, Carrier P, Naudet F, et al
    Controlled Attenuation Parameter and Liver Stiffness Measurements for Steatosis Assessment in the Liver Transplant of Brain Dead Donors.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


    January 2015
  120. OEZCELIK A, Dayangac M, Guler N, Yaprak O, et al
    Living Donor Liver Transplantation in Patients 70 Years or Older.
    Transplantation. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: